These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2743545)

  • 1. The usefulness of amiodarone in management of refractory supraventricular tachyarrhythmias.
    Tuzcu EM; Gilbo J; Masterson M; Maloney JD
    Cleve Clin J Med; 1989 May; 56(3):238-42. PubMed ID: 2743545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Oct; 31(10):1227-43. PubMed ID: 9337449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome.
    Wellens HJ; Brugada P; Abdollah H
    Am Heart J; 1983 Oct; 106(4 Pt 2):876-80. PubMed ID: 6613833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An analysis of clinical characteristics and acute treatment of supraventricular tachycardia in children from a multicenter study].
    Li XM; Ge HY; Liu XQ; Shi L; Guo BJ; Li MT; Jiang H; Zhang Y; Liu HJ; Zheng XC; Li AJ; Zhang YY
    Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):13-18. PubMed ID: 29342991
    [No Abstract]   [Full Text] [Related]  

  • 5. Amiodarone in long term management of refractory cardiac tachyarrhythmias.
    Lubbe WF; Mercer CJ; Roche AH; Lowe JB
    N Z Med J; 1981 Jan; 93(676):31-5. PubMed ID: 6940024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of digoxin in patients with paroxysmal supraventricular tachycardia].
    Smetnev AS; Titov VN; Shevchenko NM; Gurevich EM
    Kardiologiia; 1989 Apr; 29(4):61-4. PubMed ID: 2666709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
    Purcaro A; Capestro F; Ciampani N; Fratadocchi GB; Mazzanti M; Costantini C; Molini E
    G Ital Cardiol; 1987 Aug; 17(8):690-8. PubMed ID: 3121426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of amiodarone in the Wolff-Parkinson-White syndrome.
    Wellens HJ; Lie KI; Bär FW; Wesdorp JC; Dohmen HJ; Düren DR; Durrer D
    Am J Cardiol; 1976 Aug; 38(2):189-94. PubMed ID: 952262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous amiodarone is safe and seems to be effective in termination of paroxysmal supraventricular tachyarrhythmias.
    Cybulski J; Kułakowski P; Makowska E; Czepiel A; Sikora-Frac M; Ceremuzyński L
    Clin Cardiol; 1996 Jul; 19(7):563-6. PubMed ID: 8818437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous amiodarone in the acute termination of supraventricular arrhythmias.
    Holt P; Crick JC; Davies DW; Curry P
    Int J Cardiol; 1985 May; 8(1):67-79. PubMed ID: 3997293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute therapy of tachycardic arrhythmias. 2: Supraventricular tachycardia--atrioventricular tachycardia (WPW syndrome)].
    Gonska BD; Rab J
    Fortschr Med; 1995 Mar; 113(7):87-9. PubMed ID: 7750890
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and toxicity of amiodarone for the treatment of supraventricular tachyarrhythmias.
    Kopelman HA; Horowitz LN
    Prog Cardiovasc Dis; 1989; 31(5):355-66. PubMed ID: 2646656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome.
    Feld GK; Nademanee K; Stevenson W; Weiss J; Klitzner T; Singh BN
    Am Heart J; 1988 Jan; 115(1 Pt 1):102-7. PubMed ID: 3336964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial electrophysiologic abnormalities in patients with Wolff-Parkinson-White syndrome but without paroxysmal atrial fibrillation.
    Sakabe K; Fukuda N; Nada T; Shinohara H; Tamura Y; Wakatsuki T; Nishikado A; Oki T
    Clin Cardiol; 2004 Jul; 27(7):396-400. PubMed ID: 15298039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of intravenous amiodarone for short-term treatment of paroxysmal supraventricular tachycardia in children.
    Soult JA; Muñoz M; Lopez JD; Romero A; Santos J; Tovaruela A
    Pediatr Cardiol; 1995; 16(1):16-9. PubMed ID: 7753695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia].
    Manz M; Beermann J; Gerckens U; Lüderitz B
    Z Kardiol; 1986 Dec; 75(12):757-63. PubMed ID: 3825226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
    Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.
    Rowland E; Krikler DM
    Br Heart J; 1980 Jul; 44(1):82-90. PubMed ID: 7426165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy and safety of flecainide for supraventricular tachycardia.
    Neuss H; Schlepper M
    Am J Cardiol; 1988 Aug; 62(6):56D-61D. PubMed ID: 3136637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
    Kühlkamp V; Mewis C; Mayer F; Seipel L
    Z Kardiol; 1990 Oct; 79(10):725-31. PubMed ID: 2087860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.